3-MeO-PCE: Difference between revisions

>Psyched
m typo
>Psyched
m typo
Line 36: Line 36:
*'''[[Effect::Bodily control enhancement]]''' - At lower dosages this compound typically induces enhancements in bodily control. At higher dosages, this enhancement shifts towards losses in gross and fine motor control.
*'''[[Effect::Bodily control enhancement]]''' - At lower dosages this compound typically induces enhancements in bodily control. At higher dosages, this enhancement shifts towards losses in gross and fine motor control.
*'''[[Effect::Tactile enhancement]]''' & '''[[Effect::Tactile suppression]]''' - At lower dosages, this compound tends to induce tactile enhancements. At higher dosages, this enhancement shifts towards tactile suppressions and [[pain relief|anesthesia]].
*'''[[Effect::Tactile enhancement]]''' & '''[[Effect::Tactile suppression]]''' - At lower dosages, this compound tends to induce tactile enhancements. At higher dosages, this enhancement shifts towards tactile suppressions and [[pain relief|anesthesia]].
*'''[[Effect::Motor control loss]]''' - At lower dosages this compound typically induces enhancements in bodily control. At higher dosages, this enhancement shifts towards losses in gross and fine. motor control.
*'''[[Effect::Motor control loss]]''' - At lower dosages this compound typically induces enhancements in bodily control. At higher dosages, this enhancement shifts towards losses in gross and fine motor control.
*'''[[Effect::Changes in felt gravity]]'''
*'''[[Effect::Changes in felt gravity]]'''
*'''[[Effect::Appetite suppression]]'''
*'''[[Effect::Appetite suppression]]'''